These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2948780)

  • 1. Suppressor cell function and thymopeptide therapy in viral hepatitis B.
    Zhang DF; Chen GM; Fan C; Mi ZD
    Chin Med J (Engl); 1986 Oct; 99(10):791-8. PubMed ID: 2948780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spontaneous suppressor T cell function and its relation to T cell subsets in hepatitis B].
    Liu F
    Zhonghua Yi Xue Za Zhi; 1986 Sep; 66(9):514-8, 574. PubMed ID: 2947661
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.
    Chisari FV; Castle KL; Xavier C; Anderson DS
    J Immunol; 1981 Jan; 126(1):38-44. PubMed ID: 6450240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are HBsAg positive viral hepatitis and its fate caused by the genetically determined immune response to the infection?].
    Chiodo F; Vento S
    Minerva Med; 1981 Jun; 72(24):1525-9. PubMed ID: 6454091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor cell activity in viral and non-viral chronic active hepatitis.
    Tremolada F; Fattovich G; Panebianco G; Ongaro G; Realdi G
    Clin Exp Immunol; 1980 Apr; 40(1):89-95. PubMed ID: 6446433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohepatologic and clinical monitoring of neuramide therapy in acute viral hepatitis B].
    Corridori S; Trespi G; Baldini E; Campisi D; Renzetti I; Calderon W
    Boll Ist Sieroter Milan; 1985; 64(1):42-51. PubMed ID: 3159401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.
    Barnaba V; Musca A; Cordova C; Levrero M; Ruocco G; Albertini-Petroni V; Balsano F
    Clin Exp Immunol; 1983 Aug; 53(2):281-8. PubMed ID: 6224609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen specific suppressor T cells from chronic hepatitis B virus (HBV) carriers inhibit the responsiveness to HBsAg of allogeneic high-responder lymphocytes.
    Barnaba V; Levrero M; Franco A; Zaccari C; Musca A; Balsano F
    J Clin Lab Immunol; 1985 Mar; 16(3):137-42. PubMed ID: 3162024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoregulatory T subsets in chronic active viral hepatitis: characterization by monoclonal antibodies.
    Pignata C; Vajro P; Troncone R; Monaco G; Ciriaco M
    J Pediatr Gastroenterol Nutr; 1983 May; 2(2):229-33. PubMed ID: 6223993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.
    Lemm G; Salzer K; Warnatz H
    Clin Exp Immunol; 1983 May; 52(2):250-8. PubMed ID: 6222854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
    Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
    Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor cells and chronic HBV infection.
    Eddleston AL
    Prog Clin Biol Res; 1983; 143():299-307. PubMed ID: 6230678
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.
    Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS
    J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of liver-targeted regulatory T cells in hepatitis B and C virus in chronically infected patients.
    Miyaaki H; Zhou H; Ichikawa T; Nakao K; Shibata H; Takeshita S; Akiyama M; Ozawa E; Miuma S; Eguchi K
    Liver Int; 2009 May; 29(5):702-7. PubMed ID: 18673437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protective effect of thymopeptide on infection by Candida albicans in mice].
    Guo NR; Wu SX; Yong QC; Fang JL; Lu QX; Sheng DB; Mai YN; Li ZR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Oct; 8(5):399-403. PubMed ID: 2952315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunotherapy using T-activin in chronic viral hepatitis B in children].
    Nisevich NI; Uchaĭkin VF; Arion VIa; Cherednichenko TV; Shkliar GM
    Sov Med; 1986; (12):55-9. PubMed ID: 3563706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bone marrow suppressor cells of patients with viral and alcoholic liver cirrhoses].
    Khaitov RM; Dzhalalova VA; Gubarev MI; Pogromov AP; Ivlev AS
    Ter Arkh; 1986; 58(1):82-6. PubMed ID: 3008363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and viral liver disease.
    Alatrakchi N; Koziel M
    J Viral Hepat; 2009 Apr; 16(4):223-9. PubMed ID: 19222744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases.
    Pape GR; Rieber EP; Eisenburg J; Hoffmann R; Balch CM; Paumgartner G; Riethmüller G
    Gastroenterology; 1983 Sep; 85(3):657-62. PubMed ID: 6307807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunoregulation system in chronic active liver diseases of viral etiology].
    Asfandiiarova NS; Rasulova TKh; Mukhamedzhanov IV
    Sov Med; 1987; (10):15-8. PubMed ID: 2962303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.